SCHEMBL6947166

SCHEMBL6947166

CC(NC(=O)OC(C)(C)C)c1ccncc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 2/20 0.47
HDAC3 O15379 1/20 0.47
CYP2C9 P11712 1/20 0.47
HDAC4 P56524 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
HDAC9 Q9UKV0 1/20 0.47
HDAC5 Q9UQL6 1/20 0.47
CYP17A1 P05093 3/20 0.47
KMT2A Q03164 3/20 0.47
ALDH1A1 P00352 3/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
MEN1 O00255 1/20 0.47
TSHR P16473 2/20 0.45
HSD17B10 Q99714 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28784544 0.93 CTSK (0.43) CTSKHDAC3CYP2C9HDAC4HDAC1
SCHEMBL9930794 0.91 ROCK2 (0.53) CTSKCYP2C9CYP17A1ROCK2RPS6KA5
SCHEMBL9930795 0.91 ROCK2 (0.53) CTSKCYP2C9CYP17A1ROCK2RPS6KA5
SCHEMBL8216304 0.91 ROCK2 (0.53) CTSKCYP2C9CYP17A1ROCK2RPS6KA5
SCHEMBL30895333 0.84 ROCK2 (0.59) CYP17A1KMT2AALDH1A1L3MBTL1ROCK2
SCHEMBL13229732 0.84 ROCK2 (0.59) CYP17A1KMT2AALDH1A1L3MBTL1ROCK2
SCHEMBL12203593 0.83 CTSK (0.62) CTSKKMT2AALDH1A1MEN1HSD17B10
SCHEMBL6346032 0.83 CTSK (0.62) CTSKKMT2AALDH1A1MEN1HSD17B10
SCHEMBL6346030 0.83 CTSK (0.62) CTSKKMT2AALDH1A1MEN1HSD17B10
SCHEMBL28844112 0.83 ALDH1A1 (0.51) HDAC3CYP2C9HDAC4HDAC1HDAC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0674623-B1 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORP (US) 2003-04-09 EP disclosed
US-6403578-B1 ANTICOAGULANTS, CARDIOVASCULAR DISORDERS SMITHKLINE BEECHAM CORPORATION 2002-06-11 US disclosed
EP-0701568-A1 NEW PEPTIDE DERIVATIVES Astra Aktiebolag (SE) 1996-03-20 EP disclosed
EP-0674623-A1 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1995-10-04 EP disclosed
WO-1994014776-A2 BICYCLIC FIBRINOGEN ANTAGONISTS SMITHKLINE BEECHAM CORPORATION (US) 1994-07-07 WO disclosed